Human antibodies specifically binding to the hepatitis B virus surface antigen

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9200062
APP PUB NO 20140302598A1
SERIAL NO

14283300

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GREEN CROSS CORPORATION

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chang, Ki Hwan Yongin-si, KR 9 11
Hong, Kwang-Won Yongin-si, KR 11 13
Kim, Jean Man Yongin-si, KR 3 20
Kim, Min-soo Yongin-si, KR 257 2943
Kim, Se-Ho Yongin-si, KR 97 782
Koo, Sunmi Yongin-si, KR 2 5
Lee, Hae-Won Yongin-si, KR 13 97
Lee, Mijung Yongin-si, KR 15 109
Lee, Yeon Kyung Yongin-si, KR 13 103
Lim, Jung-Ae Yongin-si, KR 2 5
Ryoo, Kyung Hwan Yongin-si, KR 3 9
Seo, Dong Hyuck Yongin-si, KR 3 9
Seo, Misun Yongin-si, KR 2 5
Shin, Yong Nam Yongin-si, KR 5 35
Shin, Yong-Won Yongin-si, KR 15 110

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00